Abstract
Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Current Pharmaceutical Design
Title: Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Volume: 17 Issue: 33
Author(s): I. Gouni-Berthold and H. K. Berthold
Affiliation:
Keywords: Physician gender, quality of care, cardiovascular disease, hypertension, diabetes mellitus, chronic heart failure, blood pressure, lipid control, cardiac catheterization, glycemic control
Abstract: Evidence suggests that patient gender is associated with the quality of care provided in the treatment of cardiometabolic diseases. The majority of findings suggest that female patients receive less intensified care than male patients. However, the question whether physician gender plays a role in the quality of care has been debated for some time. For example, it has been postulated that the practice styles of female physicians, such as spending more time with a patient, hearing and listening more effectively, and including more preventive measures, may result in more efficient clinical encounters that may positively affect clinical outcomes. This narrative review examines the existing evidence regarding the effects of physician gender on the quality of care provided, focusing mainly on patients with cardiometabolic diseases.
Export Options
About this article
Cite this article as:
Gouni-Berthold I. and K. Berthold H., Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases, Current Pharmaceutical Design 2011; 17 (33) . https://dx.doi.org/10.2174/138161211798220954
DOI https://dx.doi.org/10.2174/138161211798220954 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Medicinal Chemistry Approaches for Glucokinase Activation to Treat Type 2 Diabetes
Current Medicinal Chemistry The Update of NGAL in Acute Kidney Injury
Current Protein & Peptide Science A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Letters in Drug Design & Discovery Implications of the Obesity Epidemic for Statin Therapy: Shifting Cholesterol Metabolism to a High Synthesis and Low Dietary Absorption State
Endocrine, Metabolic & Immune Disorders - Drug Targets Risk Scores and Prediction Models in Chronic Heart Failure: A Comprehensive Review
Current Pharmaceutical Design Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
Current Pharmaceutical Design Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Patent Selections
Recent Patents on Anti-Infective Drug Discovery Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes
Current Diabetes Reviews Investigating the Practices of Patients and Hospitals in Treatment of Diabetes - A Survey Questionnaire for Arabic Speaking Countries
Current Diabetes Reviews Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times
Current Cardiology Reviews Intracellular Signaling of the Aging Suppressor Protein Klotho
Current Molecular Medicine Effects of Structured Treatment Interruptions on Metabolic, Anthropometric, Immunologic, and Quality of Life Outcomes in HIV-Positive Adults on HAART
Current HIV Research Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering Immunosuppressive and Antiviral Treatment of Inflammatory Cardiomyopathy
Recent Patents on Cardiovascular Drug Discovery Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?
Current Medicinal Chemistry Meet our Editorial Board Member
Cardiovascular & Hematological Agents in Medicinal Chemistry Statin Therapy for Native and Peri-Interventional Coronary Heart Disease
Current Molecular Medicine Advances in Antithrombotic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry